NKG2D signaling in cancer immunosurveillance
Alejandro López-Soto1, Leticia Huergo-Zapico, Andrea Acebes-Huerta
1Departamento de Biología Funcional, Universidad de Oviedo, IUOPA, Asturias, Spain.
Abstract:
The immune system is able to detect and eliminate transformed cells. The activating receptor NKG2D is particularly relevant for cancer immunosurveillance. NKG2D ligand expression renders tumor cells more susceptible to be killed by NK and T cells, and correlates with the clinical outcome of the disease. However, tumors develop mechanisms to overcome the NKG2D-mediated immune response, which has been associated with poor prognosis and impairment of the clinical benefits of immunotherapy in many human cancers. The highly specific pattern of expression displayed by the NKG2D ligands, mainly confined to tumor cells, together with the strong immune response triggered by this receptor clearly supports the idea that the NKG2D-mediated pathway may be a powerful target for the treatment of cancer. This review draws together the most recent discoveries concerning the biology of the NKG2D signaling and their therapeutic relevance in the context of cancer.
Insights
The NKG2D receptor helps the immune system fight cancer by targeting transformed cells. Despite tumor defenses, targeting NKG2D signaling offers a promising strategy for cancer treatment and immunotherapy.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- The immune system surveils and eliminates transformed cells.
- NKG2D receptor and its ligands are crucial in cancer immunosurveillance.
- Tumor cells can evade NKG2D-mediated immune responses, leading to poor prognosis.
Purpose of the Study:
- To review recent discoveries on NKG2D signaling biology.
- To explore the therapeutic relevance of NKG2D in cancer treatment.
- To highlight NKG2D as a potential target for cancer immunotherapy.
Main Methods:
- Literature review of recent scientific discoveries.
- Analysis of NKG2D signaling pathways in cancer.
- Evaluation of therapeutic strategies targeting NKG2D.
Main Results:
- NKG2D ligand expression on tumor cells increases susceptibility to NK and T cell killing.
- Tumor evasion mechanisms of NKG2D-mediated immunity are associated with poor clinical outcomes.
- NKG2D pathway modulation shows therapeutic potential in various human cancers.
Conclusions:
- The NKG2D pathway is a potent target for cancer therapy due to its specific expression on tumor cells and strong immune activation.
- Understanding NKG2D biology is key to developing effective immunotherapies.
- Targeting NKG2D signaling may overcome tumor immune evasion and improve patient prognosis.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes


